Wound Debridement Global Market Report 2024

Wound debridement is a medical procedure aimed at treating skin wounds by removing dead or necrotic tissue. This process facilitates healthy tissue growth, reduces scarring, and lowers the risk of infection. Depending on the nature of the wound, debridement can be performed through surgical or non-surgical methods, such as using specific dressings and gels. Debridement helps eliminate devitalized tissue from the wound bed, promoting faster wound healing.

The main types of wound debridement include enzymatic debridement products, autolytic debridement products, gels, ointments, mechanical debridement products, ultrasonic debridement products, and others. Enzymatic wound debridement involves the use of highly selective naturally occurring proteolytic enzymes produced by the industry. Enzymatic debridement products are utilized to remove necrotic material from various types of wounds, including partial-thickness wounds, pressure ulcers, and leg ulcers. Wounds can be classified into types such as venous leg ulcers, diabetic foot ulcers, pressure ulcers, surgical and traumatic wounds, burns, and others. These wounds are treated using various methods, including surgical, enzymatic, mechanical, autolytic, and other methods. The end-users for wound debridement products include hospitals, clinics, and other healthcare facilities.

The wound debridement market research report is one of a series of new reports that provides wound debridement market statistics, including wound debridement industry global market size, regional shares, competitors with a wound debridement market share, detailed wound debridement market segments, market trends and opportunities, and any further data you may need to thrive in the wound debridement industry. This wound debridement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wound debridement market size has grown strongly in recent years. It will grow from $5 billion in 2023 to $5.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The expansion observed in the historical period can be attributed to several factors, including the heightened prevalence of chronic diseases, a growing aging population, increased healthcare expenditure, a rise in sports injuries and road accidents, and overall economic growth.

The wound debridement market size is expected to see strong growth in the next few years. It will grow to $7.03 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The anticipated growth in the forecast period can be linked to various factors, including the expanding diabetic population, the rise in outpatient care, regulatory support, an increase in the volume of surgical procedures, and the growth of healthcare infrastructure. Notable trends expected in the forecast period encompass biological debridement, robotic debridement, smart wound dressings, minimally invasive techniques, and advanced wound imaging.

The expected growth in the wound debridement market is driven by the increasing emphasis on awareness programs for wound care and management. Various factors contribute to wounds, including injuries, accidents, surgical procedures, burns, diabetes, vascular disease, and chronic wounds like leg ulcers, diabetic foot ulcers (DFUs), and pressure ulcers. Numerous wound management and prevention initiatives aim to raise awareness about the seriousness of wounds. For instance, Healogics, a US-based wound care services provider, launched the Healogics Wound Care Awareness Campaign in June 2021 to promote awareness of chronic wound healing programs. This initiative provides resources to patients and healthcare providers, aiding in health improvement, wound healing, and amputation prevention. Awareness workshops are organized to educate individuals about the severity and proper care of wounds. Thus, the increasing focus on awareness programs is propelling the growth of the wound debridement market.

The growth of the wound debridement market is anticipated to be fueled by the increasing incidence of road accidents. Road accidents, involving collisions between vehicles or pedestrians, result in injuries that necessitate wound debridement for contaminant removal, infection prevention, and enhanced wound healing. According to the World Health Organization, nearly 1.3 million people die each year from road traffic injuries, emphasizing the significant impact of road accidents. This surge in road accidents contributes to the expansion of the wound debridement market.

A prominent trend in the wound debridement market is the adoption of technological innovations. Key market players are actively engaged in developing innovative technologies for wound debridement. Recent advancements in wound care include wearable technologies, electronic health data, and various devices for examination and dressings. As an illustration, researchers from RMIT University have developed a nanosensor-infused glowing wound dressing unit with antibacterial and anti-inflammatory properties, facilitating reduced inflammation, combatting germs, and expediting the wound healing process. This technological trend underscores the ongoing advancements in wound debridement.

Major companies in the wound debridement market are incorporating new technologies, such as digital solutions for wound assessment, to enhance their service offerings. Digital solutions for wound assessment utilize technology to analyze and monitor the healing progress of wounds, providing healthcare professionals with valuable insights for patient care. Essity AB, a Sweden-based hygiene and health company, introduced Cutimed Wound Navigator in October 2021. This digital solution, available through a smart app, assists healthcare professionals in assessing and documenting wounds for patients. The app simplifies wound measurement by automatically determining key wound characteristics from captured images. This innovation highlights the industry's commitment to leveraging digital solutions for advanced wound care.

In December 2021, Essity AB expanded its presence in the wound debridement market through the acquisition of Hydrofera for USD 116 million. This strategic move aligns with Essity's goal of enhancing its medical solutions and advancing wound care capabilities, strengthening its position in the industry. Hydrofera, a US-based company specializing in wound debridement products, became part of Essity's portfolio through this acquisition.

Major companies operating in the wound debridement market include Smith & Nephew PLC, B. Braun Melsungen AG, Coloplast A/S, ConvaTec Group PLC, Lohmann & Rauscher International, Integra LifeSciences Corporation, Arobella Medical LLC, Medline Industries Inc., Acelity L.P. Inc., DeRoyal Industries Inc., Histologics LLC, ArthoCare Corporation, Advanced Medical Solutions Group, Söring GmbH, Bactiguard AB, Zimmer Biomet Holdings Inc., Monarch Labs, Mölnlycke Healthcare, Advancis Medical, RLS Global Inc., Sanara MedTech Inc., MDM Wound Ventures Inc., Derma Sciences Inc., 3M Company, Hollister Incorporated, Human Biosciences Inc., Misonix Inc., BSN medical GmbH, AtoZ Healing Technologies LLC, BioMonde Ltd., Bionix Development Corporation, Celleration Inc., Covalon Technologies Ltd., Devon Medical Inc., E-QURE Corp., EKare Inc.

North America was the largest region in the wound debridement market in 2023. Asia-Pacific is expected to be the fastest-growing region in the wound debridement market report during the forecast period. The regions covered in the wound debridement industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the wound debridement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The wound debridement market consists of sales of surgical debridement, enzymatic debridement, autolytic, and biological. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.